Competitive Projects

Cutting-edge neuro projects

Competitive Projects

These projects address a variety of topics related to neurodegenerative diseases such as ALS and related conditions, and are funded by various entities including ministries, foundations, and talent attraction programs. Our research team leads and collaborates on projects that seek to better understand the causes, mechanisms, and potential therapies for these debilitating diseases.

  • CI25-20156: “A TDP-43 sensor for the diagnosis of neurodegenerative diseases”. CaixaImpulse Innovacion 2025. Fundación la Caixa. 01/11/2025- 31/10/2027. 150.000 €. Contribution: Co-Principal investigator.
  • PID2023-147947OB-I00: “Unravelling the role of TDP43 in the modification of the cognitive alterations induced by changing metabolic risk factors through diets”. Ministerio de Ciencia e Innovación. 01/09/2024-31/08/2027. 218.750 €. Contribution: Principal investigator.
  • PMPER24/00017: “SEED-ALS: Synergizing Efforts to Develop and Accelerate Breakthroughs in ALS Research”. ISCIII Medicina de precisión. PL: Adolfo López de Munain. 01/01/2025-31/12/2026. 3.937.239 €. Contribution: Collaborator.
  • SCS.P04.PAIE.24: “Development of biomarkers for early diagnosis of TDP-43 proteinopathies in blood”. FUNDACION PARA LA INVESTIGACION HOSPITAL CLINICO SAN CARLOS. 01/11/2024-31/01/2026. 40.000 €. Contribution: Principal investigator.
  • RED2022-134774-T: “Extracellular vesicles-mediated extrasynaptic regulation of neuronal function in neurodegenerative diseases”. Ministerio de Ciencia e Innovación. Redes temáticas 2022. PL: Jimena Baleriola. 19.000 €. Contribution: Principal investigator.
  • 2022-5A/BMD-24221: “Unravelling the causal relation of cholesterol alterations in ALS and its potential treatment in SOD1 mice”. Attraction of Talent program- 5th year. Comunidad de Madrid. 08/07/2023- 07/07/2024. 30.000 €. Contribution: Principal Investigator.
  • SCS.CAM.22: “Study of alterations in lipid metabolism in patients with ALS: Working on prevention”. Ministerio de Sanidad- Strategic Funds for Neurodegenerative disorders 2022. 01/09/2022-01/04/2023. 10.000 €. Contribution: Principal investigator.
  • PID2020-115370RB-I00: “Deciphering the causal role of body Lipid metabolism in delineating cognitive and motor clinical alterations in the ALS-FTD spectrum of disorders”. Ministerio de Ciencia e Innovación. 01/10/2021 - 30/09/2024. 157.300 €. Contribution: Principal Investigator.
  • Significance of brain glucose hypometabolism and of altered insulin signal transduction in an experimental model of amyotrophic lateral sclerosis (ALS). Fundacion Ramon Areces. PI: Enrique Blazquez. 01/09/2018-31/12/2022. Contribution: PI Collaborator.
  • AGS.MIS.21: “Study of alterations in lipid metabolism in patients with ALS and froto-temporal dementia”. Strategic Funds for Neurodegenerative disorders 2021-Ministerio de Sanidad- PI: Antonio Guerrero. 01/09/2021-0104/2022. 10.000 €. Contribution: Co-Principal investigator.
  • 2018-T1/BMD-10731: “Identifying BMI-associated pathways that confer protection in ALS”. Attraction of Talent program. Comunidad de Madrid. 08/07/2019-07/07/2023. HCSC -IdISSC. 199.962 €. Contribution: Principal Investigator.
  • “Investigating a novel role for the epilepsy gene TBC1D24 in vesicular acidification”. Epilepsy research UK. PI: Peter Oliver. 26/03/2018 - 31/12/2019. MRC-Harwell UK. 35.000 €. Contribution: Co- Principal Investigator.
  • “Studying the impact of muscle alterations on neurological diseases”. The Royal Society, UK. 03/2015-03/2016. 19.000 €. Contribution: Principal Investigator. *R